P3 Health Partners (PIII) Competitors $8.91 +0.26 (+3.01%) Closing price 03:59 PM EasternExtended Trading$8.78 -0.13 (-1.40%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PIII vs. VMD, XGN, DCGO, CORBF, QIPT, SERA, BNR, ATPC, EUDA, and BDSXShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), Sera Prognostics (SERA), Burning Rock Biotech (BNR), Agape ATP (ATPC), EUDA Health (EUDA), and Biodesix (BDSX). These companies are all part of the "healthcare" industry. P3 Health Partners vs. Its Competitors Viemed Healthcare Exagen DocGo Global Cord Blood Quipt Home Medical Sera Prognostics Burning Rock Biotech Agape ATP EUDA Health Biodesix P3 Health Partners (NASDAQ:PIII) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment. Does the media favor PIII or VMD? In the previous week, P3 Health Partners' average media sentiment score of 0.00 equaled Viemed Healthcare'saverage media sentiment score. Company Overall Sentiment P3 Health Partners Neutral Viemed Healthcare Neutral Which has better valuation and earnings, PIII or VMD? Viemed Healthcare has lower revenue, but higher earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioP3 Health Partners$1.46B0.04-$135.85M-$46.01-0.19Viemed Healthcare$224.26M1.19$11.27M$0.3420.21 Is PIII or VMD more profitable? Viemed Healthcare has a net margin of 5.80% compared to P3 Health Partners' net margin of -9.99%. Viemed Healthcare's return on equity of 10.38% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets P3 Health Partners-9.99% -183.60% -17.83% Viemed Healthcare 5.80%10.38%7.88% Which has more risk & volatility, PIII or VMD? P3 Health Partners has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500. Do insiders & institutionals have more ownership in PIII or VMD? 7.8% of P3 Health Partners shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 17.8% of P3 Health Partners shares are owned by insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend PIII or VMD? P3 Health Partners currently has a consensus price target of $16.25, suggesting a potential upside of 82.38%. Given P3 Health Partners' higher possible upside, equities analysts clearly believe P3 Health Partners is more favorable than Viemed Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score P3 Health Partners 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Viemed Healthcare 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryViemed Healthcare beats P3 Health Partners on 10 of the 13 factors compared between the two stocks. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIII vs. The Competition Export to ExcelMetricP3 Health PartnersMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$64.04M$2.27B$6.10B$10.61BDividend YieldN/AN/A5.64%4.70%P/E Ratio-0.1937.2585.6627.12Price / Sales0.0445.51526.70205.97Price / CashN/A60.2026.3031.12Price / Book0.8412.7312.906.66Net Income-$135.85M-$63.46M$3.30B$275.95M7 Day Performance-6.80%4.77%4.79%3.31%1 Month Performance1.60%8.12%8.10%10.75%1 Year Performance-52.86%38.97%75.73%33.53% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIP3 Health Partners2.5405 of 5 stars$8.91+3.0%$16.25+82.4%-54.2%$64.04M$1.46B-0.19500VMDViemed Healthcare1.3557 of 5 stars$6.62-1.3%N/A-17.1%$260.25M$224.26M19.471,179XGNExagen4.1631 of 5 stars$10.77-1.1%$12.00+11.4%+265.3%$239.62M$55.64M-12.10220Positive NewsDCGODocGo1.4668 of 5 stars$1.38+0.7%$3.24+134.6%-62.1%$134.00M$435.97M-7.264,407CORBFGlobal Cord BloodN/A$1.00+400.0%N/A-42.9%$121.55M$196.12M0.001,200Gap DownQIPTQuipt Home Medical1.7672 of 5 stars$2.62-2.2%$3.15+20.2%-6.8%$116.43M$245.91M-10.921,200SERASera Prognostics0.8292 of 5 stars$3.05-1.3%N/A-54.9%$116.41M$80K-3.59120Positive NewsBNRBurning Rock Biotech0.441 of 5 stars$9.42+5.5%N/A+146.4%$96.11M$70.67M-4.961,390ATPCAgape ATP0.8142 of 5 stars$1.25-1.6%N/A-36.0%$63.51M$1.45M-3.0540Positive NewsEUDAEUDA Health1.2212 of 5 stars$1.69-0.9%N/A-42.1%$63.17M$4.01M0.002Gap UpBDSXBiodesix3.6494 of 5 stars$7.74-0.1%$32.50+319.9%-77.1%$56.82M$71.32M-1.33220News Coverage Related Companies and Tools Related Companies VMD Competitors XGN Competitors DCGO Competitors CORBF Competitors QIPT Competitors SERA Competitors BNR Competitors ATPC Competitors EUDA Competitors BDSX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PIII) was last updated on 10/6/2025 by MarketBeat.com Staff From Our Partners$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredGet my No. 1 gold stock nowGold recently broke past $3,800 per ounce – setting yet another new all-time high. And Wall Street banks sa...Stansberry Research | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
